Your browser doesn't support javascript.
loading
Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.
Yu, Xiao-Juan; Li, Juan; Lin, Zhi-Jie; Zhao, Hui; Lin, Bi-Zhen; Qiao, You-Lin; Hu, Yue-Mei; Wei, Li-Hui; Li, Rong-Cheng; Huang, Wei-Dan; Wu, Ting; Huang, Shou-Jie; Li, Chang-Gui; Pan, Hui-Rong; Zhang, Jun.
Afiliação
  • Yu XJ; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics(SCIBP), School of Public Health, Xiamen University , Xiamen, Fujian,
  • Li J; Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control , Beijing, China.
  • Lin ZJ; Vaccine R&D Department, Xiamen Innovax Biotech Company , Xiamen, Fujian, China.
  • Zhao H; Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control , Beijing, China.
  • Lin BZ; Vaccine R&D Department, Xiamen Innovax Biotech Company , Xiamen, Fujian, China.
  • Qiao YL; Department of Cancer Epidemiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing, China.
  • Hu YM; Department of Vaccine Evaluation, Jiangsu Provincial Center for Disease Control and Prevention , Nanjing, Jiangsu, China.
  • Wei LH; Department of Obstetrics and Gynecology, Peking University People's Hospital , Beijing, China.
  • Li RC; Center for Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention , Nanning, Guangxi, China.
  • Huang WD; Vaccine R&D Department, Xiamen Innovax Biotech Company , Xiamen, Fujian, China.
  • Wu T; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics(SCIBP), School of Public Health, Xiamen University , Xiamen, Fujian,
  • Huang SJ; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics(SCIBP), School of Public Health, Xiamen University , Xiamen, Fujian,
  • Li CG; Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control , Beijing, China.
  • Pan HR; Vaccine R&D Department, Xiamen Innovax Biotech Company , Xiamen, Fujian, China.
  • Zhang J; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics(SCIBP), School of Public Health, Xiamen University , Xiamen, Fujian,
Hum Vaccin Immunother ; 16(7): 1630-1635, 2020 07 02.
Article em En | MEDLINE | ID: mdl-32544361
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2020 Tipo de documento: Article